LatestOpinion: The science on relieving cancer symptoms is clear. Why isn't insurance paying?
Health

Brain scans reveal a possible cause of long COVID fatigue and brain fog

Brain scans reveal a possible cause of long COVID fatigue and brain fog
COVID-19
Summary

Researchers have discovered that long COVID may damage dopamine-releasing neurons in the brain, potentially explaining persistent fatigue, low motivation, slowed movement, and memory difficulties. This groundbreaking finding, revealed through advanced brain imaging, provides the first neurological evidence of how the virus affects cognitive and physical function long after the acute infection resolves. The damage to the dopamine system—a critical neurotransmitter involved in motivation, movement, and memory—could explain why many long COVID patients struggle with debilitating fatigue that doesn't improve with rest. This discovery opens new avenues for targeted treatments that could restore dopamine function and significantly improve quality of life for the millions suffering from long COVID symptoms.

Science Daily

Originally published on

ScienceDaily Health

Read full article(opens in new tab)

Fetched: September 22, 2026 at 10:01 AM

More news you might be interested in

View all
Opinion: The science on relieving cancer symptoms is clear. Why isn't insurance paying?
Health
AnxietyCancer

Opinion: The science on relieving cancer symptoms is clear. Why isn't insurance paying?

Research demonstrates that integrative therapies effectively reduce cancer-related pain, fatigue, anxiety, and nausea, yet insurance companies frequently deny coverage for these evidence-based treatments. These complementary approaches, used alongside conventional cancer care, have shown significant clinical benefits in improving quality of life for cancer patients. Despite scientific validation, patients face financial barriers accessing therapies like acupuncture, massage, meditation, and nutritional counseling. This coverage gap raises important questions about insurance policies and patient access to proven symptom management strategies during cancer treatment.

yesterday
STAT News
Opinion: Social Media Bans Are Spreading Globally—How Will Researchers Measure Teen Health Impact?
Health
AnxietyDepression

Opinion: Social Media Bans Are Spreading Globally—How Will Researchers Measure Teen Health Impact?

As countries worldwide implement social media bans targeting teenagers, researchers face a critical opportunity to study the real-world effects on adolescent mental health and wellbeing. Camilla Iannone from Wellcome emphasizes that rigorous scientific examination is essential to understand whether these regulatory measures actually improve teen outcomes. The debate centers on social media's documented links to anxiety, depression, and other mental health concerns among young people. Without systematic research during this period of regulatory change, policymakers and parents won't have concrete evidence about effectiveness. Expert consensus suggests coordinated studies are needed to evaluate both the benefits and potential harms of social media restrictions on adolescent development.

yesterday
STAT News
GOP Health Expert Maintains Support for $1 Trillion in Medicaid Cuts
Health

GOP Health Expert Maintains Support for $1 Trillion in Medicaid Cuts

An influential Republican health policy expert continues to advocate for substantial cuts to Medicaid, the federal health program that covers millions of Americans, including vulnerable populations. The proposal targets $1 trillion in reductions to the program, raising concerns about healthcare access for low-income individuals and those with chronic conditions. This stance reflects ongoing debates within the GOP about federal spending priorities and healthcare policy direction. The expert's continued support for these cuts signals potential future policy targets within the healthcare system that could affect patient coverage and medical services.

yesterday
STAT News
Ohio Governor's Race Tests Public Trust in Science and Pandemic Response
Health
COVID-19

Ohio Governor's Race Tests Public Trust in Science and Pandemic Response

The Ohio gubernatorial race between Amy Acton and Vivek Ramaswamy represents a critical referendum on healthcare policy, COVID-19 response, and public confidence in scientific guidance. This election serves as a bellwether for how American voters view pandemic management and healthcare costs in the crucial heartland region. The candidates' contrasting positions on disease prevention, healthcare access, and scientific authority reflect broader national divisions on these vital issues. Their debate on these topics will influence policy decisions affecting millions of residents and could shape future public health approaches across the nation.

yesterday
STAT News